Natus Medical has announced a public offering of 770,000 shares of its common stock at a price of $18.27 per share, which is equal to the closing price of the company's common stock on the NASDAQ global market on April 3, 2008.
Subscribe to our email newsletter
The company expects that the net proceeds of the offering will be approximately $13.4 million after deducting underwriting discounts and other expenses associated with the offering. The company currently intends to use the net proceeds for general corporate purposes, which may include the financing of potential acquisitions of, or investments in, companies and technologies that complement the company’s business, as well as for capital expenditures and working capital needs.
In connection with the offering, the company also granted the underwriter a 30-day option to purchase up to an additional 115,500 shares to cover over-allotments, if any. The offering is expected to close on or about April 9, 2008. Roth Capital Partners acted as the sole underwriter of the offering.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.